Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Insomnia, Malaise, Myalgia, Nausea
Clinical narrative: Small bruise at injection site after the 2nd dose; Anxiety; loss of Appetite; balance issues; hands shacky; Brain fog; MRI confirmed Bursitis; soreness continued to worsen expanded to neck; General Feeling of  unwellness; soreness continued to worsen expanded to shoulder blade entire shoulder upper arm to elbow; Injection was inserted too high on left arm; body aches, arm soreness(left); fever; headaches, frequent headaches; nausea, frequent nausea; fatigue, Chronic fatigue; left arm soreness, soreness continued to worsen; pain; flu symptoms; Insomnia; jittery, jitteryness; 2nd dose on 20 JUl 2021; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Small bruise at injection site after the 2nd dose), INFLUENZA (flu symptoms), INSOMNIA (Insomnia), FEELING JITTERY (jittery, jitteryness) and ANXIETY (Anxiety) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040C21A and 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021 at 5:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose on 20 JUl 2021). On 21-Jul-2021, the patient experienced INFLUENZA (flu symptoms), INSOMNIA (Insomnia), FEELING JITTERY (jittery, jitteryness), PAIN (pain), PAIN IN EXTREMITY (left arm soreness, soreness continued to worsen), PYREXIA (fever), HEADACHE (headaches, frequent headaches), NAUSEA (nausea, frequent nausea), FATIGUE (fatigue, Chronic fatigue) and MYALGIA (body aches, arm soreness(left)). On 24-Jul-2021, the patient experienced VACCINATION SITE BRUISING (Small bruise at injection site after the 2nd dose), ANXIETY (Anxiety), DECREASED APPETITE (loss of Appetite), BALANCE DISORDER (balance issues), TREMOR (hands shacky), FEELING ABNORMAL (Brain fog), BURSITIS (MRI confirmed Bursitis), NECK PAIN (soreness continued to worsen expanded to neck), MALAISE (General Feeling of  unwellness), ARTHRALGIA (soreness continued to worsen expanded to shoulder blade entire shoulder upper arm to elbow) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Injection was inserted too high on left arm). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 20-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose on 20 JUl 2021) had resolved. On 24-Jul-2021, INFLUENZA (flu symptoms), INSOMNIA (Insomnia), FEELING JITTERY (jittery, jitteryness), PYREXIA (fever), HEADACHE (headaches, frequent headaches), NAUSEA (nausea, frequent nausea), FATIGUE (fatigue, Chronic fatigue) and MYALGIA (body aches, arm soreness(left)) had resolved with sequelae. At the time of the report, VACCINATION SITE BRUISING (Small bruise at injection site after the 2nd dose) had resolved, ANXIETY (Anxiety), DECREASED APPETITE (loss of Appetite), BALANCE DISORDER (balance issues), TREMOR (hands shacky), PAIN (pain), FEELING ABNORMAL (Brain fog), BURSITIS (MRI confirmed Bursitis), NECK PAIN (soreness continued to worsen expanded to neck), MALAISE (General Feeling of  unwellness), ARTHRALGIA (soreness continued to worsen expanded to shoulder blade entire shoulder upper arm to elbow) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Injection was inserted too high on left arm) had not resolved and PAIN IN EXTREMITY (left arm soreness, soreness continued to worsen) had resolved with sequelae.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.   This case was linked to MOD-2021-278663 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Patient demographics, dose details and new events were added.